Location: DIBI1, Floor 1, Room 36
Deputy scientific director, IRCCS Ospedale San Raffaele
Group leader, Immunopathology Unit
Full professor, Università Vita-Salute San Raffaele
Luca G. Guidotti (LGG), is an experimental pathologist of international renown in the field of viral hepatitis. LGG spent more than 20 years as a Faculty of the Scripps Research Institute in La Jolla, California and he currently serves as Deputy scientific director of the IRCCS Ospedale San Raffaele in Milan. Over the years, LGG has published his work in some of the most prestigious scientific journals such as Cell, Nature, Science, Nature Medicine, Journal of Clinical Investigation, Journal of Experimental Medicine and others. His research activities have been financed by several agencies that include the National Institute of Health (NIH) and the European Research Council (ERC). LGG has been a member of numerous Study Sections at the NIH and the ERC for the allocation of funds to biomedical research.
2022-present: Member, Comitato Tecnico Scientifico (CTS), Ricerca Sanitaria, Ministero della Salute; Scientific & Technical Committee, Biomedical Research, Italian Ministry of Health, Rome, Italy
2021: Member, Scientific Advisory Board, Antios Therapeutics, Mendham, N.J., USA
2018-present: Member, Board of Directors, Genenta Science S.p.A. (Nasdaq GNTA)
2017-present: Member, International Coalition to Eliminate Hepatitis B virus (ICE-HBV), Melbourne, Australia
2015-present: Member and Deputy Spokesman, Research4life, Milan, Italy
2013-present: Member, Gilead Sciences "HBV CURE Advisory Board", Foster City, CA, USA.
2010-2016: Recipient, European Research Council (ERC) Advanced Grant: “Imaging liver immunopathology by intravital microscopy (IVM).
2008-present: Member, Eureka Institute for Translational Medicine.
2004: Honorary Member, Academic Society of Philosophy and Medicine, University of Parma.
2004-2021: Co-founder and Member of the Board of Capitalife Inc., Reno, Nevada, USA.
2003: Member, NIH/NIAID Advisory Panel for the Study of Liver Diseases.
2001: Gold Medal for excellence in Antiviral Research, Schering Plough Japan, Tokyo, Japan.
1998-present: Member, Organizing Committee, Annual International Meeting on Hepatitis B Viruses.
1996-2014: Recipient, NIH RO1 Grant AI40696: “Regulation of HBV replication by the immune system”.